Find Academic Supervisors

• Cancer Biomarkers
• Translational Cancer Research
• Digital Pathology
• +3 more

Lill-Tove Rasmussen Busund is a Professor and Consultant Pathologist at the Department of Medical Biology, UiT The Arctic University of Norway. Her research focuses on translational cancer studies with emphasis on cancer biomarkers in tissue and blood, combining molecular biology with artificial intelligence applications in pathology. She leads the Translational Cancer Research Group (TCRG) and contributes to projects like the TNM-Immune Cell Score Trial and AI–Pathology initiatives. Role: Professor/Consultant Pathologist University: UiT The Arctic University of Norway Department: Department of Medical Biology Email: lill.tove.rasmussen.busund@uit.no Rasmussen Busund's work spans epidemiological cancer research , multi-omic data integration , and machine learning applications for cancer diagnostics. She develops prognostic and predictive biomarkers using population-based cohorts like the NOWAC study, with particular attention to hormone-dependent cancers and immune microenvironment analysis . Recent publications highlight her expertise in digital pathology and AI-driven tumor classification , including studies on microRNA expression patterns in breast and colon cancer, immune cell score development for NSCLC, and computational approaches to lymphocytic infiltration assessment. Her research directly impacts precision oncology and immunotherapy response prediction . She contributes to teaching as leader of the Musculoskeletal System course at the Medical School, and maintains active participation in scientific knowledge migration projects like the transition to the National Science Archive (NVA). Her ORCID identifier is 0000-0001-8235-6163 .

• Perinatal Epidemiology
• Reproductive Health
• Vitamin D Research
• +5 more

Anne Marie Jukic, PhD, MSPH serves as an Adjunct Assistant Professor in the Department of Chronic Disease Epidemiology at the Yale School of Public Health. Her research focuses on perinatal epidemiology with emphasis on the pre-conception period, pregnancy outcomes, and child health. Dr. Jukic's research interests include: Early pregnancy events, particularly implantation and placental development Vitamin D's role in reproductive health and fertility Environmental exposures (phthalates and phenols) and their impact on pregnancy Menstrual cycle function as a vital sign for reproductive health Physical activity during pregnancy and pregnancy outcomes Her publications reveal strong trends in digital epidemiology, vitamin D research, and environmental impacts on reproductive health. Recent work leverages large digital cohorts to investigate menstrual patterns, PCOS prediction, and androgen excess across the lifespan. She maintains active collaborations with Norwegian research teams studying placental development and childhood neurodevelopment. Scientific recognition includes: Rising Star Award (2016) from Society for Pediatric and Perinatal Epidemiologic Research Young Investigator Award (2016) from Vitamin D Workshop NIEHS Paper of the Month (2015) Poster Award (2015) from Society for Epidemiologic Research Student Travel Award (2012) from Society for Epidemiologic Research Dr. Jukic directs research within the Yale Center for Perinatal, Pediatric and Environmental Epidemiology (CPPEE), investigating how environmental, genetic, and clinical factors impact pregnancy and childhood health. Her current projects include studies on ambient air pollution and miscarriage, vitamin D and cycle regularity, and microRNA in early placental development.

• Biosensors
• Bio-nanotechnology
• Bioregenerative Life Support
• +4 more

Dr. D. Marshall Porterfield is a Professor of Agricultural & Biological Engineering at Purdue University, specializing in biosensors, bio-nanotechnology, and space biology. His research focuses on developing technologies for bioregenerative life support systems and nutrient delivery in microgravity environments. He served as NASA's Division Director for Space Life and Physical Sciences (2012-2016), pioneering initiatives like geneLAB and materialsLAB to advance space research utilization. His work bridges engineering and biology, with applications in space exploration and terrestrial challenges. Porterfield holds leadership roles in organizations like the American Society for Gravitational and Space Research and the Institute for Biological Engineering. He has authored over 100 peer-reviewed papers and holds patents in biosensor technology. Awards include the Halstead Investigator Award and election to the AIMBE College of Fellows. His research portfolio includes lab-on-a-chip devices, biomimetic sensors, and gravitational physiology studies, with recent emphasis on lunar agriculture and space radiation mitigation. His articles highlight advancements in space microbiology, extraterrestrial crop systems, and molecular responses to spaceflight. Key themes include optimizing oxygen delivery for hydroponics, detecting cancer biomarkers via microtest tech, and understanding aging in space environments. Porterfield collaborates across disciplines, leveraging Purdue's facilities like the Birck Nanotechnology Center and Discovery Park for interdisciplinary innovation.

Alan DombkowskiView profile

Professor

• Molecular Neuroscience
• Genomics
• Bioinformatics
• +4 more

Alan Dombkowski is a Professor of Pediatrics at Wayne State University School of Medicine, specializing in molecular mechanisms of neurological disorders through genomic and bioinformatic approaches. Key research focus: Epileptogenic potential of cortical tubers in Tuberous Sclerosis Complex (TSC) Methods: Next-gen sequencing, microarrays, proteomics, and epigenetic analysis of human brain tissue Current projects funded by federal grants examining microRNA regulation and therapeutic targets in epilepsy Recent publications span: 2024: Cisplatin-induced cochlear synaptic proteomics 2023: Multi-omic biomarkers for prostate cancer aggressiveness 2021: Exosomal miRNA in TSC epilepsy 2018: Neuroinflammatory mechanisms in pediatric epilepsy Collaborations include Harry Chugani (neuroimaging), Diane Chugani (neurochemistry), Eishi Asano (epileptology), and Paul Stemmer (molecular pharmacology).

• Surgical Oncology
• Gastrointestinal Surgery
• Pancreatic Cancer
• +3 more

Professor Jochen Gaedcke is an active surgical oncology specialist at University Medical Center Göttingen's Faculty of Medicine, Department of Surgery. His supervisory role spans 15 doctoral theses from 2017-2025, demonstrating his sustained academic leadership in gastrointestinal and cancer research. Position: Professor of Surgery Supervision Period: 2017-2025 (ongoing) Thesis Topics: Primarily focused on gastrointestinal malignancies and surgical outcomes Professor Gaedcke's research centers on surgical oncology with particular emphasis on pancreatic and colorectal cancers. His work investigates tumor microenvironment characteristics (particularly fibrosis in pancreatic cancer), molecular mechanisms of treatment response (KRAS mutations, p53 pathways), and clinical outcomes following gastrointestinal procedures. His supervision portfolio reveals a consistent focus on improving diagnostic methods, treatment efficacy, and complication management in visceral surgery. Analysis of his supervised publications shows a strong trend toward translational research bridging basic science discoveries with clinical applications. Approximately 60% of the theses focus on gastrointestinal cancers (pancreatic, colorectal, gastric), 25% on surgical complications and outcomes, and 15% on diagnostic innovations. The work demonstrates increasing sophistication in molecular analysis techniques over time, with recent theses incorporating advanced biomarker discovery and personalized treatment approaches. Professor Gaedcke has supervised 15 doctoral candidates to completion between 2017-2025, indicating a robust mentoring program. His students have investigated diverse aspects of surgical oncology, with several focusing on pancreatic cancer (3 theses), colorectal cancer (4 theses), and diagnostic methods (3 theses). This mentoring activity demonstrates his central role in training the next generation of surgical researchers in Germany. His laboratory work appears to focus on tumor microenvironment analysis, particularly the role of fibrosis in pancreatic cancer progression and treatment response. The collaborative nature of his work is evident from co-authorship on multiple publications with colleagues across pathology, molecular biology, and clinical departments.

Xiaonan ZHANGView profile

Associate Professor

• Virology
• Molecular Biology
• Translational Medicine
• +4 more

Xiaonan ZHANG is an Associate Professor in the Faculty of Science and Technology at the University of Canberra, leading the Hepatitis B Virus (HBV) Group within the Centre for Research into Therapeutic Solutions. He holds a PhD from Fudan University (2012) and previously worked at the Shanghai Public Health Clinical Centre until 2021. His research focuses on HBV molecular pathogenesis, therapeutic vaccine development, and next-generation sequencing applications in viral infections. His work has advanced understanding of HBV’s clinical outcomes, including the discovery of Capsid-Antibody-Complexes (CACs) and their role in pathogenesis. Collaborations span institutions like the Peter Doherty Institute, University of Queensland, and international partners such as Fudan University and University of Duisburg-Essen. Key projects include: Development of therapeutic mRNA vaccines for chronic HBV Clinical evaluation of CAC assays in HBV/HIV co-infections Metagenomic sequencing for pathogen identification Research interests emphasize translational medicine, with contributions to H7N9 influenza and SARS-CoV-2 studies during the pandemic. His team pioneered real-world analyses of viral and host factors in COVID-19 outcomes. Current focus includes liver-resident immune cell dynamics and novel diagnostic assays for HBV nucleic acids. Publications highlight innovations in HBV cccDNA tracking, immune complex mechanisms, and exosome-mediated signaling. No scientific awards were explicitly listed in the provided texts. Xiaonan actively collaborates on grants and supervises PhD students, advancing interdisciplinary approaches to viral diseases.

Shankar MukherjiView profile

Assistant Professor

• Biophysics
• Quantitative Biology
• Systems Biology
• +3 more

Shankar Mukherji is an Assistant Professor of Physics at Washington University in St. Louis, affiliated with the Department of Physics and the Center for Quantum Leaps. His research integrates theoretical and experimental approaches to understand the design principles governing cellular function, with a focus on organelle biogenesis, spatial organization, and systems-level coordination. He holds a PhD in Biomedical Engineering from the Harvard-MIT Division of Health Science and Technology, and completed postdoctoral training at Harvard’s FAS Center for Systems Biology under Erin O’Shea. Key research themes include: (1) how cells regulate organelle abundance, size, and spatial distribution under developmental/environmental cues, (2) the interplay between organelle biogenesis and cellular physiology, and (3) engineering cellular decision-making to control organelle properties. His group employs advanced imaging, synthetic biology, and computational modeling techniques. Recent work emphasizes systems-level analysis of organelle networks, uncovering principles linking cellular growth to organelle allocation. Notable contributions include studies on stochastic fluctuations in organelle abundance, resource competition models, and the biophysical limits governing organelle formation. Courses taught include Biophysics Laboratory (Physics 360) and Calculus-based Physics (Physics 191). His research has been highlighted in high-impact journals like Cell Systems, Nature, and Science. Current projects explore nanodiamond-based quantum sensing for organelle detection and synthetic biology approaches to reprogram organelle biogenesis pathways.

Joshua EdelView profile

Professor

• Analytical Chemistry
• Medical Biotechnology
• Human Biophysics
• +3 more

Joshua Edel is a Professor of Biosensing & Analytical Sciences at Imperial College London's Department of Chemistry within the Faculty of Natural Sciences. He specializes in developing trace analyte analytical platforms, including bioanalytical sensors for clinical applications. His work focuses on single-molecule detection, nanopore sensors, and microfluidic systems. Edel has published over 180 research articles and secured prestigious grants like the ERC Starting Grant (2011) and ERC Consolidator Award (2017). His research spans nanobiotechnology, plasmonic sensors, and biosensor innovation. Education: PhD in developing single-molecule detection within microfluidic systems from Imperial College London (2003). Postdoctoral research at Cornell University (School of Applied and Engineering Physics) and a fellowship at Harvard University's Rowland Institute (single-molecule biophysics). Research Interests: Edel’s lab pioneers techniques such as high-throughput droplet microfluidics, optical/electrical single-molecule sensors, and plasmonic nanopore sensors. His work addresses challenges in diagnostics, nanoelectronics, and structural chemistry. Key areas include developing selective biosensors for clinical samples and advancing nanoscale probing technologies. Grants & Awards: ERC Starting Grant (2011): Rare event bioanalysis ERC Consolidator Award (2017): Selective single-molecule biosensors Funding from EPSRC, Wellcome Trust, and industrial partners Advising & Labs: Edel leads projects in Imperial’s Department of Chemistry and collaborates across disciplines. His lab develops cutting-edge tools like nanoscale tweezers for single-cell analysis and nanofluidic platforms for biomarker detection. He actively consults in biosensing technology.

• Biomedical polymers
• Nano-gene/drug carriers
• Biotherapy
• +3 more

Prof. Huayu Tian is a Nan Qiang Distinguished Professor at the Department of Chemistry, College of Chemistry and Chemical Engineering, Xiamen University. With a Ph.D. in Polymer Chemistry and Physics from Changchun Institute of Applied Chemistry (CAS), he leads research in biomedical polymers and nanocarriers for gene/drug delivery. B.S. (1994-1998): Polymer Materials, Harbin Institute of Technology M.S. (1998-2000): Materials Science, Harbin Institute of Technology Ph.D. (2002-2005): Polymer Chemistry, Changchun Institute His work focuses on biomedical polymers , nanocarriers for gene therapy , nucleic acid vaccines , and immunotherapy , with applications in cancer treatment and sepsis management . Recent publications highlight photothermal-immunotherapy combinations , MOF-based drug systems , and microenvironment-responsive nanomaterials . Notable awards include: Jilin Province Natural Science Award (First Prize, 2021) National Outstanding Youth Fund (China) Youth Innovation Promotion Association, CAS (2016)

Chase BroederszView profile

Associate Professor

• Cell Migration
• Chromosome Organization
• Biopolymer Mechanics
• +3 more

Chase Broedersz is an Associate Professor at Vrije Universiteit Amsterdam, affiliated with the Faculty of Science's Physics of Living Systems department and the LaserLaB - Energy research group. He leads interdisciplinary research on cell migration, chromosome mechanics, and active matter, combining experimental and theoretical approaches. His work contributes to UN Sustainable Development Goals related to health and innovation. Research Interests: Focus on cell migration dynamics , chromosome organization , biopolymer mechanics , and nonlinear elasticity . Recent studies explore bacterial chromosome topology, metastasis prevention mechanisms, and 3D nuclear deformation during cell movement. His methods include Hi-C data analysis, single-molecule tweezers, and computational modeling. Publications Trends: Recent work emphasizes chromosome condensation mechanics , active matter dynamics , and nonlinear elasticity in biopolymers . Key 2024-2025 studies include ion-mediated mitotic chromosome mechanics and metastasis suppression by miR-200c. Awards: None explicitly listed. Grants/Advising: Supervised one PhD thesis and contributes to datasets like biopolymer matrix nonlinear elasticity studies. Labs/Teams: Active in LaserLaB and collaborates internationally on cell migration and chromosome physics.

Vassilis P. PlagianakosView profile

Associate Professor

• Machine Learning
• Neural Networks
• Bioinformatics
• +5 more

Vassilis P. Plagianakos is an Associate Professor at the Department of Computer Science and Biomedical Informatics, University of Thessaly, Greece. He has held visiting academic roles at the University of the Aegean, University of Patras, and University of Central Greece. He currently serves as the Department Head and Director of the postgraduate program Informatics and Computational Biomedicine in the School of Sciences. His research focuses on machine learning, neural networks, bioinformatics, and parallel computing with applications in healthcare and education. Education : Bachelor’s in Mathematics (1996), University of Patras Ph.D. in Mathematics (2003), University of Patras Research Interests : Plagianakos explores neural networks, evolutionary algorithms, and machine learning applications in bioinformatics, medical diagnosis, and educational technology. His work bridges computational methods with real-world challenges in healthcare (e.g., precision medicine) and STEM education (e.g., flipped classrooms, AI integration). Recent Trends in Publications : Recent work emphasizes predictive precision medicine using big data, blockchain scalability solutions, and AI ethics in automated content detection. He has pioneered methods like the HCER hierarchical clustering-ensemble regressor and developed tools for analyzing single-cell RNA sequencing data. Professional Activities : Member of IEEE Neural Networks Society, IEEE BBTC, and former Board Member of the Hellenic AI Society. Active in collaborative projects like CrowdHEALTH for policy-driven health data analytics.

Shoib SiddiquiView profile

Senior Lecturer

• Cancer Biology
• Immunology
• Glycobiology
• +4 more

Dr. Shoib Siddiqui is a Senior Lecturer at the University of Hertfordshire's School of Life and Medical Sciences, specializing in cancer biology, immunology, and glycobiology. Previously, he held positions at the American University of Ras Al Khaimah and conducted postdoctoral research at UC San Diego under Prof. Ajit Varki. His research focuses on sialic acids, Siglecs, and microRNA mechanisms in cancer, Alzheimer’s, and sepsis. He earned his Ph.D. from ETH Zurich, investigating neuropilin-2 in skin cancer progression. Education: Ph.D. in Vascular Biology, Immunology, and Cancer Biology (ETH Zurich, 2009–2013) M.Sc. in Biotechnology (IIT Bombay, 2008) Research Focus: Dr. Siddiqui’s work explores cancer progression pathways, tumor biomarkers, and novel therapies. Key areas include Siglec-sialoglycan interactions, microRNA targeting, and drug repurposing for colorectal cancer. His recent projects involve developing RNAi therapeutics and inhibitors for Siglec-15. Projects: Fluralaner as a Colorectal Cancer Therapeutic (2026–2027) ADAMTS-7 Inhibition for Coronary Artery Disease (2022) UK-China Mycotoxin Reduction Alliance (2022–2023) Publications: Over 39 peer-reviewed articles in journals like Journal of Clinical Investigation , PNAS , and Blood , with a focus on oncology, glycobiology, and immunology. Recent trends emphasize Siglec-targeted therapies, microRNA networks, and drug repurposing strategies. Awards: No formal awards listed, but noted for impactful publications in high-impact journals. Advising & Grants: Served as Principal Investigator (PI) on RNAi therapeutics and Co-Investigator (CoI) on Siglec-15 and ADAMTS-7 projects. Collaborations span international institutions and cross-disciplinary teams. Labs/Teams: Active in the Biosciences Research Group and Centre for Research in Mechanisms of Disease and Drug Discovery at UH. Collaborates with global researchers in glycobiology and oncology.

Michael R AbernView profile

Associate Professor

• Urologic Oncology
• Prostate Cancer Biomarkers
• Quantitative Imaging
• +3 more

Michael R. Abern, MD, is an Associate Professor in the Department of Urology at Duke University and a member of the Duke Cancer Institute. He completed his medical degree at Rush University Medical College (2006) and undergraduate studies at the University of Illinois (1996). His clinical practice and research focus on urologic malignancies, with particular expertise in prostate and bladder cancers. Dr. Abern's research integrates three primary domains: 1) Biomarker development for early prostate cancer detection and risk stratification, especially in multiethnic populations; 2) Advanced quantitative imaging techniques for genitourinary cancers; and 3) Surgical innovation in robotic and minimally invasive urologic oncology. His work consistently addresses racial disparities in cancer outcomes, with multiple studies focused on optimizing care for African American and Hispanic populations. His recent publications demonstrate a strong focus on improving diagnostic accuracy through novel biomarkers (Stockholm3 test, microRNAs) and imaging modalities (biparametric MRI, blue-light cystoscopy), refining risk assessment tools for diverse populations, and evaluating genomic testing's impact on treatment decisions. Therapeutic investigations span bladder cancer immunotherapy, oligometastatic disease management, and surgical technique optimization. Dr. Abern leads several major clinical trials as Principal Investigator, including: A Phase III study of Atezolizumab for high-risk bladder cancer (Genentech, 2023-2029) Droplet surgical drain for minimal residual disease detection (Droplet Biosciences, 2024-2029) Phase I/IIa study of STM-416 for recurrent bladder cancer (Surge Therapeutics, 2024-2029) Urolithin A supplementation trial for prostate cancer (Northwestern University, 2024-2025)

Teresa A. ZimmersView profile

Professor

• Cancer Cachexia
• Pancreatic Cancer
• Muscle Wasting and Atrophy
• +7 more

Teresa A. Zimmers is a Professor at Indiana University with extensive expertise in cancer cachexia, muscle wasting, and translational oncology. She holds a Ph.D. from The Johns Hopkins University School of Medicine (2001), a B.S. from Massachusetts Institute of Technology (1990), and completed postdoctoral training at the University of Rochester (2001-2003). Dr. Zimmers leads prominent academic initiatives as President of the Cancer Cachexia Society and co-organizer of international conferences including the 2023 Cancer Cachexia Conference and 2024 Keystone Conference. Her multidisciplinary research focuses on: Molecular mechanisms of cancer cachexia and muscle atrophy Sex-specific differences in cancer progression Pancreatic cancer pathophysiology Inflammatory signaling in organ injury Translational approaches for metabolic wasting disorders She maintains active memberships in the American Association for Cancer Research, Shock Society, and Society on Sarcopenia, Cachexia and Wasting Diseases. Honors recognizing her contributions include: Alliance of Distinguished and Titled Professors (Indiana University, 2019) Sigma Xi Honor Society (2019) Cancer Researcher of the Year (Women’s Cancer Association, 2009) Distinguished Investigator Award (University of Miami, 2005)

Denise DoolanView profile

Professor

• Molecular Immunology
• Vaccinology
• Infectious Diseases
• +5 more

Professor Denise Doolan is an Affiliate Professor in The University of Queensland's School of Chemistry and Molecular Biosciences and Deputy Director (Research) at the Institute for Molecular Bioscience (IMB). She previously served as Deputy Director of the Australian Institute of Tropical Health and Medicine and Director of the JCU Centre for Molecular Therapeutics. Her research focuses on molecular immunology, vaccine development, and omics-based approaches to combat infectious and chronic diseases, particularly malaria and Epstein-Barr virus (EBV)-related malignancies. She leads cross-disciplinary programs in antigen discovery, host-pathogen immunity, and biomarker development, leveraging genome-based technologies and human disease models. Academic Positions: Affiliate Professor, Deputy Director (IMB), Affiliate of Centre for Superbug Solutions Executive Roles: President of International Society for Vaccines (2021–2023), Member of Australian Medical Research Advisory Board Her research interests include vaccine engineering, systems immunology, and therapeutic development. Key projects involve identifying EBV protein signatures linked to Multiple Sclerosis and malaria immunity profiling using controlled human infection models. She is renowned for her work in malaria immunology and omics-based diagnostics, recognized with Fellowships from the International Society for Vaccines and Australian Society of Parasitology. Recent publications highlight her work on EBV antibody responses in lymphomas, malaria vaccine candidates, and molecular diagnostics for vascular diseases. She actively supervises PhD students in areas like EBV-MS links and malaria systems immunology, supported by grants from NIH, MS Research Australia, and ARC. Scientific Awards: ISV Fellowship (2017), ASP Fellowship (2019) Grants: NIH-funded malaria vaccine projects, EBV-MS diagnostics (MS Research Australia) Her lab collaborates on developing point-of-care tests and next-generation vaccines, emphasizing translational research to address global health challenges.